I'll go to the second question first because I think that is a really important thing, and that is one of the recommendations that came out of my report.
Yes, injectable therapy is working for some people. It's very difficult to get into. There are a very small number in terms of access to programs, but we also know that people's use of drugs has changed over time, and people are not injecting as frequently. We know that smoking is the much more common way that people are using drugs now, so we need to have formulations that people are able to use in that way. We've heard from people who use drugs that it's what they need as well. To be able to separate them from the toxic drugs that are on the street right now, we need to ramp up those programs. My recommendations are that these start as directly observed therapy programs, but it needs to be accessible to people.
The other problem that we have is that we can't prescribe our way out of this. We have to have ways that people can develop those relationships with a clinic. I think the Hope to Health clinic is a good example of this. People can get the medications that they need to keep them on that road, away from using the street drugs as much as possible and in the formulations that they need.
It should be witnessed as a way to start. Then, you develop that relationship over time and that trust with people, because we also know that it's very difficult for people to stay in these treatment programs when they have to go in multiple times a day or every single day. If something happens where they need to be with family or they miss the bus, or there's something dramatic happening that day and they don't get their dose, that's when we know that people go back to accessing what they can find on the streets, for example.
Absolutely, I think these are the things that we...and I've recommended that we look at how we scale up access to the prescribed substances that people need and will use. That's another way of minimizing diversion, which is a symptom of unmet needs.